Related Experiment Video
Updated: Mar 22, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Lactobacillus rhamnosus GG Intake Modifies Preschool Children's Intestinal Microbiota, Alleviates
Katri Korpela1, Anne Salonen1, Lauri J Virta2
1Department of Bacteriology and Immunology, Immunobiology Research Programme, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Insights
Long-term Lactobacillus rhamnosus GG (L. rhamnosus GG) supplementation influences children's gut microbiota composition. This probiotic may prevent some antibiotic-associated microbiota changes and reduce gastrointestinal complaints.
Area of Science:
- Microbiology
- Pediatric Gastroenterology
- Clinical Nutrition
Background:
- Antibiotic use significantly disrupts the developing intestinal microbiota in children, leading to gastrointestinal issues.
- Probiotics are often recommended to mitigate antibiotic-associated gastrointestinal symptoms, but their impact on children's microbiota remains unclear.
- The long-term effects of probiotic consumption on the pediatric gut microbiome are not well understood.
Purpose of the Study:
- To investigate the influence of long-term Lactobacillus rhamnosus GG (L. rhamnosus GG) intake on children's antibiotic use and associated gastrointestinal complaints.
- To analyze the effect of L. rhamnosus GG on the composition of the intestinal microbiota in preschool children.
- To determine if L. rhamnosus GG can prevent antibiotic-associated changes in the gut microbiota and reduce gastrointestinal symptoms.
Main Methods:
- A double-blind, randomized placebo-controlled trial involving 231 children aged 2-7 years.
- Long-term supplementation with L. rhamnosus GG or placebo.
- Analysis of intestinal microbiota composition in a subset of 88 children.
Main Results:
- Long-term L. rhamnosus GG supplementation altered gut microbiota composition, increasing Prevotella, Lactococcus, and Ruminococcus, while decreasing Escherichia.
- The probiotic partially prevented microbiota changes associated with penicillin but not macrolide antibiotic use.
- L. rhamnosus GG reduced the frequency of gastrointestinal complaints following macrolide antibiotic courses and potentially prevented infections for up to 3 years.
Conclusions:
- Long-term L. rhamnosus GG supplementation impacts the developing intestinal microbiota in children.
- This probiotic may offer benefits in managing antibiotic-associated gastrointestinal disturbances and potentially reducing infection incidence.
- Further research is warranted to fully elucidate the mechanisms and long-term implications of probiotic use in pediatric populations.
Unlabelled:
Antibiotic use is considered among the most severe causes of disturbance to children's developing intestinal microbiota, and frequently causes adverse gastrointestinal effects ranging from mild and transient diarrhoea to life-threatening infections. Probiotics are commonly advocated to help in preventing antibiotic-associated gastrointestinal symptoms. However, it is currently unknown whether probiotics alleviate the antibiotic-associated changes in children's microbiota. Furthermore, it is not known how long-term probiotic consumption influences the developing microbiota of children. We analysed the influence of long-term Lactobacillus rhamnosus GG intake on preschool children's antibiotic use, and antibiotic-associated gastrointestinal complaints in a double blind, randomized placebo-controlled trial with 231 children aged 2-7. In addition, we analysed the effect of L. rhanmosus GG on the intestinal microbiota in a subset of 88 children. The results show that long-term L. rhamnosus GG supplementation has an influence on the composition of the intestinal microbiota in children, causing an increase in the abundance of Prevotella, Lactococcus, and Ruminococcus, and a decrease in Escherichia. The treatment appeared to prevent some of the changes in the microbiota associated with penicillin use, but not those associated with macrolide use. The treatment, however, did reduce the frequency of gastrointestinal complaints after a macrolide course. Finally, the treatment appeared to prevent certain bacterial infections for up to 3 years after the trial, as indicated by reduced antibiotic use.
Trial Registration:
ClinicalTrials.gov NCT01014676.
More Related Videos
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Probiotics
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Microbiota of the Stomach and Small Intestine
Gut-Brain Axis

